US 10786461
Onapristone extended-release compositions and methods
granted A61KA61K31/575A61K9/20
Quick answer
US patent 10786461 (Onapristone extended-release compositions and methods) held by CONTEXT BIOPHARMA, INC. expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CONTEXT BIOPHARMA, INC.
- Grant date
- Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/575, A61K9/20, A61K9/2054, A61P